Maternal Determinants of HIV-exposed and HIV-unexposed Fetal Growth, Birth Outcomes and Early Infant Growth

This study has been completed.
Information provided by (Responsible Party):
Cornell University Identifier:
First received: July 18, 2012
Last updated: September 26, 2013
Last verified: September 2013
The purpose of this study is to understand how differences in the nutritional status and concentration of hormones and cytokines associated with cachexia in HIV+ and HIV- pregnant women living in a semi-rural and rural region of northern Tanzania affect fetal growth, pregnancy outcomes and early infant health and development. The study hypothesis is that HIV+ women will have worse nutritional status and a greater degree of cachexia which will negatively impact fetal growth, pregnancy outcomes and early infancy health and development.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Cornell University:

Primary Outcome Measures:
  • Maternal cachexia score [ Time Frame: Up to 1 month post-partum ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Maternal anthropometric measures [ Time Frame: Up to 1 month post-partum ] [ Designated as safety issue: No ]
    weight, height, mid-upper arm circumference, triceps skinfold, fundal height

  • Fetal growth [ Time Frame: Up to 1 month post-partum ] [ Designated as safety issue: No ]
  • Pregnancy outcomes [ Time Frame: Up to 1 month post-partum ] [ Designated as safety issue: No ]
    spontaneous abortion, stillbirth, preterm delivery, perinatal mortality (death within first 7 days), neonatal mortality (death within first 28 days), small for gestational age, intrauterine growth retardation, low birth weight

  • Early infant anthropometrics [ Time Frame: Up to 1 month post-partum ] [ Designated as safety issue: No ]
    weight, length, head circumference, mid-upper arm circumference, triceps skinfold

Enrollment: 218
Study Start Date: April 2012
Study Completion Date: July 2013
Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
Pregnant women and infants
HIV+ and HIV- pregnant women, HIV-exposed and HIV-unexposed infants, ARV-exposed and ARV-unexposed infants


Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
HIV+ and HIV- women and their infants attending a semi-rural clinic and/or rural dispensaries for their antenatal and early infancy care in north western Tanzania

Inclusion Criteria:

  • Informed consent provided by mothers, and parental consent on behalf of their infants
  • Confirmed HIV status (HIV-1, HIV-2 or HIV-Dual seropositive or HIV-seronegative)
  • Estimated gestational age between 12th and 34th weeks
  • Stated intention to remain in the clinic catchment area ≥6 months post-partum
  • Singleton birth

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01647841

Kisesa Health Centre
Kisesa, Tanzania
Sponsors and Collaborators
Cornell University
Principal Investigator: Joann M. McDermid, PhD, RD Cornell University
  More Information

Responsible Party: Cornell University Identifier: NCT01647841     History of Changes
Other Study ID Numbers: IRB 1111002615 
Study First Received: July 18, 2012
Last Updated: September 26, 2013
Health Authority: United States: Institutional Review Board
Tanzania: National Institute for Medical Research

Additional relevant MeSH terms:
Nutrition Disorders processed this record on May 25, 2016